Clinical trial Recruiting at 4 sites Phase 3 Interventional Ages 18 to 45 Women only

Effects of Metformin on Pregnancy Outcomes in Gestational Diabetes

Official title: Pregnancy Outcomes: Effects of Metformin Study (POEM Study), a Long Term Randomized Controlled Study in Gestational Diabetes

Run by Bethesda Diabetes Research Center · NCT02947503 · Data updated 2026-11-12

This study tests if taking metformin along with diet and lifestyle changes can improve pregnancy outcomes for women with gestational diabetes and their babies.

More Insulin Resistance trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment500 (estimated)
SponsorBethesda Diabetes Research Center
Academic / other
Locations4 sites (Groningen and 3 other locations)
StatusRecruiting
StartedNovember 26, 2019
Main results expectedDecember 2043
Study endsDecember 2043
Registry record updatedFebruary 10, 2022
Trial IDNCT02947503 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women aged 18-45 with a diagnosis of gestational diabetes between 16-32 weeks of gestation.

Probably not a fit

Patients with pre-existing diabetes, severe renal or liver disease, or significant psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The POEM study investigates the impact of metformin on pregnant women diagnosed with gestational diabetes mellitus (GDM). This randomized controlled trial compares two groups: one receiving metformin alongside diet and lifestyle changes, and the other receiving diet and lifestyle changes alone. The study aims to assess various pregnancy outcomes at delivery and long-term health effects for both mother and child. It consists of three phases, including an observational extension to evaluate outcomes up to 20 years post-delivery.

Why it matters

Potential benefit: If successful, this study could significantly reduce complications associated with gestational diabetes for both mothers and their children.

How similar studies have gone: Previous observational studies suggest potential benefits of metformin in managing gestational diabetes, but this is the first randomized controlled trial of its kind.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women with GDM defined as a Fasting Plasma Glucose (FPG) \> 5,3 mMol and/or an Oral Glucose Tolerance test (OGTT) with a Plasma glucose (PG) \> 7,8 mMol, two hours after the oral intake of 75 gram glucose
* Written informed consent
* Age 18-45 years
* Gestational age at inclusion 16-32 weeks
* Glycohemoglobin test (HbA1c) at inclusion ≤ 48 mmol/mol (6.5% Hb)

Exclusion Criteria:

* Diabetes mellitus before pregnancy, except previous GDM
* Proteinuria: Urine Albumin-to-Creatinine Ratio (UACR) \> 35 mg/mmol at screening
* Malignancy during the last 5 years before inclusion, except non-melanoma skin cancer
* Psychiatric and/or mood disorder potentially affecting compliance of treatment
* Chronic liver disease and/or Alanine aminotransferase aspartate transaminase (ASAT) and/or Alanine aminotransferase (ALAT) \> 3x Upper Limit of Normal (ULN).
* Chronic renal failure with a Glomerular filtration rate (GFR) \< 45 ml/min/1.73m2
* Chronic pulmonary failure with hypoxia
* Significantly uncontrolled hypertension - Systolic blood pressure (SBP) \> 160 mm Hg despite medical treatment
* Chronic treatment with corticosteroids
* Intolerance for metformin and/or earlier use of metformin in this pregnancy
* Membership of the POEM study group
* Severe foetal anomaly at inclusion - like major neural tube and/or cardiac malformation
* Ruptured membranes
* Multiple pregnancy
* Inability to understand or read the Dutch language
* Bariatric surgery in medical history
* Hyperemesis gravidarum

Where it's running

  • Martini hospital Groningen
    Groningen, Netherlands
    Recruiting
  • University Medical Center Groningen
    Groningen, Netherlands
    Recruiting
  • Treant Zorggroep
    Hoogenveen, Emmen, Stadskanaal, Netherlands
    Recruiting
  • Medical Center Leeuwarden
    Leeuwarden, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.